References Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P
Counteraction of Perforated Cecum Lesions in Rats: Effects of Pentadecapeptide BPC 157, L-NAME and L-Arginine
The most common is subcutaneous injection from a reconstituted vial
GutBrain Axis & Cytoprotection Gutbrain axis and BPC-157 pathways suggest a cytoprotective effect in models of gastrointestinal injury and stress
Note: TB-500 is not FDA-approved for any clinical indication
Where combinations affect planning is in overall budget and protocol length decisions